Glioblastoma is one of the most malignant and aggressive tumors of the central nervous system. Despite the standard therapy consisting of maximal surgical resection and chemo- and radiotherapy, the median survival of patients with this diagnosis is about 15 months. Oncolytic virus therapy is one of the promising areas for the treatment of malignant neoplasms. In this review, we have focused on emphasizing recent achievements in virotherapy, both as a monotherapy and in combination with other therapeutic schemes to improve survival rate and quality of life among patients with glioblastoma.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10889383 | PMC |
| http://dx.doi.org/10.3390/ijms25042042 | DOI Listing |
Publication Analysis
Top Keywords
combination oncolytic
4
oncolytic virotherapy
4
virotherapy antitumor
4
antitumor approaches
4
approaches glioblastoma
4
glioblastoma glioblastoma
4
glioblastoma malignant
4
malignant aggressive
4
aggressive tumors
4
tumors central
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!